STTK
Closed
Shattuck Labs inc
0.8156
+0.0238 (+3.01%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 0.7918
Day's Range: 0.7921 - 0.91
Send
sign up or login to leave a comment!
When Written:
3
Shattuck Labs Inc is a clinical-stage biotechnology company that focuses on developing and commercializing cancer treatments. The company's proprietary technology platform, Agonist Redirected Checkpoint (ARC), harnesses the power of the immune system to attack cancer cells. Shattuck Labs is based in Austin, Texas, and was founded in 2016. The company's lead product candidate, SL-172154, is currently in Phase 1 clinical trials for the treatment of solid tumors. The company has partnerships with Takeda Pharmaceutical Company Limited and Astellas Pharma Inc. to develop and commercialize its ARC technology.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








